Free Trial

Germany limits travel from French region over virus variant

Dominik uses a banner that is set up together with fitness equipment on a field on the outskirts of Berlin, Saturday, Feb.27, 2021. The fitness chain McFit has set it up for open-air training for anyone who wants to work out here. This is also to protest against the ongoing closures of fitness centers. (Jens Kalaene/dpa via AP)

BERLIN (AP) — Germany announced Sunday that travelers from France’s northeastern Moselle region will face additional restrictions because of the high rate of variant coronavirus cases there.

Germany's disease control agency, the Robert Koch Institute, said it would add Moselle to the list of “variant of concern” areas that already includes countries such as the Czech Republic, Portugal, the United Kingdom and parts of Austria.

Travelers from those areas must produce a recent negative coronavirus test before entering Germany.

The Moselle region in northeastern France includes the city of Metz and borders the German states of Saarland and Rhineland-Palatinate.

Clement Beaune, the French minister for European affairs, said France regrets the decision and is in negotiations with Germany to try to lighten the measures for 16,000 inhabitants of Moselle who work across the border. Specifically, he said France does not want them to face the daily PCR virus tests that Germany has applied elsewhere to travelers along some borders.

“We don’t want that,” he said.

Beaune said France is pushing for the use of easier, faster testing methods and for tests every 2-3 days rather than daily. More talks were expected later Sunday, he said.

The weekly rate of new infections in Moselle, at more than 300 per 100,000 people, is well above the average for France’s eastern region and the national average. In Germany, the number of cases per week currently stands at almost 64 per 100,000 inhabitants.

The Robert Koch Institute recorded 7,890 newly confirmed cases of COVID-19 in Germany over the past day, taking the total to over 2.4 million cases. The death toll rose by 157 to 70,045.

German officials have warned that virus variants such as the one first detected in Britain — known as B.1.1.7 — could spread more easily and fuel the infection rate at a time when Germany is slowly relaxing its lockdown measures.

“There are two trains rushing toward each other,” said Karl Lauterbach, an epidemiologist and lawmaker with the center-left Social Democrats.

He called for Germany to prioritize giving as many people as possible an initial vaccine dose, as some other countries have done, including with the AstraZeneca shot currently reserved for those under 65. Companies and schools should also carry out weekly tests, or more once possible, and those with a negative result should also be able to visit stores again.

Bavaria's governor, Markus Soeder, also urged a change to the way the AstraZeneca shot is used. The vaccine has been shunned by many hoping to get the shot made by German company BioNTech and Pfizer, or a similar one made by U.S. firm Moderna.

Soeder said Sunday it was “an absurd situation” that many who want to get vaccinated can't, while those who can don't want to.

“Whatever is left over should just be released,” he said.

___

Follow all of AP’s pandemic coverage at:

https://apnews.com/hub/coronavirus-pandemic

https://apnews.com/hub/coronavirus-vaccine

https://apnews.com/UnderstandingtheOutbreak

Should You Invest $1,000 in Pfizer Right Now?

Before you consider Pfizer, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Pfizer wasn't on the list.

While Pfizer currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Companies Mentioned in This Article

CompanyMarketRankâ„¢Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Pfizer (PFE)
4.976 of 5 stars
$25.450.5%6.76%18.44Hold$28.55
Compare These Stocks  Add These Stocks to My Watchlist 

Featured Articles and Offers

Recent Videos

3 Cheap Growth Stocks Set to Explode This Summer
The Next NVIDIA? Quantum Computing Stocks Set for Explosive Growth
5 Stocks to BUY NOW in July 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines